Arabesque Asset Management LTD Dexcom Inc Transaction History

Arabesque Asset Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $724,773 - $1.42 Million	10,660 Added 281.41%	14,448 $1.08 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $3,246 - $4,070	25 Added 0.66%	3,788 $2.03 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $401,549 - $538,786	3,763 New	3,763 $2.06 Million
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $800,564 - $946,746	-8,382 Closed	0 $0
Q2 2020 Oct 22, 2020	BUY	$62.68 - $105.34 $525,383 - $882,959	8,382 New	8,382 $3.4 Million
Q1 2020 Apr 17, 2020	SELL	$47.79 - $75.63 $501,747 - $794,039	-10,499 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$36.62 - $57.29 $384,473 - $601,487	10,499 New	10,499 $2.3 Million

1,085

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Arabesque Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Arabesque Asset Management LTD with notifications on news.